OPRE Study: National Survey of Child and Adolescent Well-Being Second Cohort (NSCAW III): Data Collection (Phase III - Caseworker Surveys) [Longitudinal Study]

ICR 202101-0970-002

OMB: 0970-0202

Federal Form Document

Forms and Documents
Document
Name
Status
Justification for No Material/Nonsubstantive Change
2021-01-11
Supplementary Document
2021-01-11
Supplementary Document
2021-01-11
Supporting Statement B
2021-01-11
Supporting Statement A
2021-01-11
Supplementary Document
2020-06-22
Supplementary Document
2020-06-22
Supplementary Document
2020-06-22
Supplementary Document
2020-06-22
Supplementary Document
2020-06-22
Supplementary Document
2020-06-22
Supplementary Document
2020-06-22
Supplementary Document
2020-06-22
Supplementary Document
2020-06-22
Supplementary Document
2020-06-22
Justification for No Material/Nonsubstantive Change
2019-12-13
Justification for No Material/Nonsubstantive Change
2019-07-30
Justification for No Material/Nonsubstantive Change
2019-04-15
Supplementary Document
2017-04-20
Supplementary Document
2021-01-11
Supplementary Document
2021-01-11
Supplementary Document
2021-01-11
Supplementary Document
2021-01-11
ICR Details
0970-0202 202101-0970-002
Received in OIRA 202006-0970-007
HHS/ACF OPRE
OPRE Study: National Survey of Child and Adolescent Well-Being Second Cohort (NSCAW III): Data Collection (Phase III - Caseworker Surveys) [Longitudinal Study]
No material or nonsubstantive change to a currently approved collection   No
Regular 01/11/2021
  Requested Previously Approved
09/30/2023 09/30/2023
3,815 3,815
5,391 5,103
0 0

Since March 2020, NSCAW III data collection has been paused due to the COVID-19 pandemic. A total of 3,083 caregiver, 2,188 child, and 2,003 caseworker baseline interviews and 181 caregiver, 143 child, and 20 caseworker follow-up interviews were completed prior to the data collection pause. The contractor has an Infectious Disease Response Team that is closely monitoring COVID-19 metrics rates in the participating NSCAW III counties to determine when it may be safe to resume face-to-face interviewing. The purpose of the current request is to obtain approval for minor revisions to the Phase II study protocol and materials to reflect the impact of the COVID-19 pandemic, compliance with 2018 HHS human subjects and HIPAA Privacy Rule requirements, and the addition of a non-monetary incentive for adolescent participants ages 11 to 17.

US Code: 42 USC 626b Name of Law: Continuing Appropriations Act of 2020
  
None

Not associated with rulemaking

  85 FR 6198 02/04/2020
85 FR 38898 06/29/2020
No

  Total Request Previously Approved Change Due to New Statute Change Due to Agency Discretion Change Due to Adjustment in Estimate Change Due to Potential Violation of the PRA
Annual Number of Responses 3,815 3,815 0 0 0 0
Annual Time Burden (Hours) 5,391 5,103 0 0 288 0
Annual Cost Burden (Dollars) 0 0 0 0 0 0
No
No
Timing data collected during NSCAW III indicates that the average administration times for baseline and follow-up child interviews take longer than the initial 80-minute estimate and instead take 105 and 90 minutes, respectively. This is largely due to higher administration times among adolescents in comparison to younger children. The team examined the protocols to ensure that only necessary information is included.

$3,549,385
Yes Part B of Supporting Statement
    Yes
    No
No
No
No
Yes
Molly Buck 202 205-4724 mary.buck@acf.hhs.gov

  No

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
 
 
 
 
 
 
 
    (i) Why the information is being collected;
    (ii) Use of information;
    (iii) Burden estimate;
    (iv) Nature of response (voluntary, required for a benefit, or mandatory);
    (v) Nature and extent of confidentiality; and
    (vi) Need to display currently valid OMB control number;
 
 
 
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
01/11/2021


© 2024 OMB.report | Privacy Policy